Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/22/24 16:52 | 11/21/24 | RGEN | Health | BioPrd | Biological Products, (No Diag | Hunt Anthony | MA | D | 4 | S.d | -13,288 | 159.68 | 0 | -83 | 185 | D | ||||||||||||||||
8/5/24 21:56 | 8/2/24 | RGEN | Health | BioPrd | Biological Products, (No Diag | Kuriyel Ralf | MA | O | SVP,R,D | 3 | S.d | -2,560 | 169.21 | 0 | -15 | 24 | D | |||||||||||||||
2/28/24 21:56 | 2/27/24 | RGEN | Health | BioPrd | Biological Products, (No Diag | Dawes Karen A | MA | D | 2 | S.d | -339 | 183.26 | 0 | -2 | 87 | D | ||||||||||||||||
2/26/24 20:38 | 2/23/24 | RGEN | Health | BioPrd | Biological Products, (No Diag | Bylund James | MA | O | COO | 1 | S.d | -866 | 198.08 | 0 | -4 | 14 | D | |||||||||||||||
11/13/23 17:10 | 11/10/23 | RGEN | Health | BioPrd | Biological Products, (No Diag | Gebski Christine | MA | O | See Rema | 1 | S | -557 | 147.13 | 0 | -4 | 29 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |